Calcium regulating hormones in healthy elderly men: relation to intestinal calcium absorption. 1994

G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
Istituto di Patologia Speciale Medica e Metodologia Clinica, Università di Bologna.

Aged male subjects often have osteoporosis and it has been suggested that the cause is an age-related lack of vitamin D. We evaluated the calcium regulating endocrine mechanism in healthy aged males in order to verify this hypothesis. We studied serum levels of PTH and 1,25(OH)2D in relation to intestinal calcium absorption, radial bone mass density (BMD) and osteocalcin plasma levels in 30 healthy elderly men (61-88 yr.). 1,25(OH)2D levels and calcium absorption, assessed by oral strontium test, did not change with age with respect to a young control group. PTH was higher (p < 0.02) in the elderly than in the control group, and correlated positively with nephrogenous cAMP levels (p < 0.01; r = 0.65). Radial BMD (measured by single photon absorptiometry) was lower (p < 0.01) in elderly than in young subjects and negatively correlated with age (p < 0.01; r = -0.45). Osteocalcin levels, used as a mark of bone turnover, were unchanged. The data suggest that decreased 1,25(OH)2D levels are not a feature of normal male aging. Senile hyperparathyroidism could compensate for impairments in endogenous metabolism of vitamin D in elderly males and maintain calcium absorption at an efficient level, without increasing bone turnover.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004872 Ergocalciferols Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24. Calciferols,Vitamin D 2,Ergocalciferol,Vitamin D2,D2, Vitamin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
August 1991, Endocrinologia japonica,
G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
February 1998, Clinical endocrinology,
G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
March 1988, Nihon Seikeigeka Gakkai zasshi,
G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
February 2004, European journal of clinical nutrition,
G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
December 1995, Clinical and experimental pharmacology & physiology. Supplement,
G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
March 2009, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
January 1984, Hormone research,
G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
August 1983, The American journal of clinical nutrition,
G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
November 1986, Annals of internal medicine,
G Ravaglia, and P Forti, and F Maioli, and R C Scali, and F Boschi, and L Pratelli, and A Pizzoferrato
January 1974, Biomembranes,
Copied contents to your clipboard!